spacer
spacer

PDBsum entry 1v3v

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Oxidoreductase PDB id
1v3v

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
333 a.a. *
Ligands
NAP ×2
5OP ×2
Metals
_CL ×6
Waters ×945
* Residue conservation analysis
PDB id:
1v3v
Name: Oxidoreductase
Title: Crystal structure of leukotriene b4 12-hydroxydehydrogenase/15-oxo- prostaglandin 13-reductase complexed with NADP and 15-oxo-pge2
Structure: Leukotriene b4 12-hydroxydehydrogenase/prostaglandin 15- keto reductase. Chain: a, b. Synonym: leukotriene b4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase. Engineered: yes
Source: Cavia porcellus. Domestic guinea pig. Organism_taxid: 10141. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Dimer (from PQS)
Resolution:
2.00Å     R-factor:   0.194     R-free:   0.239
Authors: T.Hori,T.Yokomizo,H.Ago,M.Sugahara,G.Ueno,M.Yamamoto,T.Kumasaka, T.Shimizu,M.Miyano,Riken Structural Genomics/proteomics Initiative (Rsgi)
Key ref:
T.Hori et al. (2004). Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. J Biol Chem, 279, 22615-22623. PubMed id: 15007077 DOI: 10.1074/jbc.M312655200
Date:
06-Nov-03     Release date:   13-Jul-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9EQZ5  (PTGR1_CAVPO) -  Prostaglandin reductase 1 from Cavia porcellus
Seq:
Struc:
329 a.a.
333 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: E.C.1.3.1.48  - 15-oxoprostaglandin 13-reductase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. 13,14-dihydro-15-oxo-prostaglandin E2 + NADP+ = 15-oxoprostaglandin E2 + NADPH + H+
2. 13,14-dihydro-15-oxo-prostaglandin E2 + NAD+ = 15-oxoprostaglandin E2 + NADH + H+
13,14-dihydro-15-oxo-prostaglandin E2
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= 15-oxoprostaglandin E2
+ NADPH
+ H(+)
13,14-dihydro-15-oxo-prostaglandin E2
+
NAD(+)
Bound ligand (Het Group name = NAP)
matches with 91.67% similarity
= 15-oxoprostaglandin E2
+ NADH
+ H(+)
   Enzyme class 2: E.C.1.3.1.74  - 2-alkenal reductase [NAD(P)(+)].
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. an n-alkanal + NAD+ = an alk-2-enal + NADH + H+
2. an n-alkanal + NADP+ = an alk-2-enal + NADPH + H+
n-alkanal
+
NAD(+)
Bound ligand (Het Group name = NAP)
matches with 91.67% similarity
= alk-2-enal
+ NADH
+ H(+)
n-alkanal
+
NADP(+)
Bound ligand (Het Group name = NAP)
corresponds exactly
= alk-2-enal
+ NADPH
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M312655200 J Biol Chem 279:22615-22623 (2004)
PubMed id: 15007077  
 
 
Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop.
T.Hori, T.Yokomizo, H.Ago, M.Sugahara, G.Ueno, M.Yamamoto, T.Kumasaka, T.Shimizu, M.Miyano.
 
  ABSTRACT  
 
The bifunctional leukotriene B(4) 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase (LTB(4) 12-HD/PGR) is an essential enzyme for eicosanoid inactivation. It is involved in the metabolism of the E and F series of 15-oxo-prostaglandins (15-oxo-PGs), leukotriene B(4) (LTB(4)), and 15-oxo-lipoxin A(4) (15-oxo-LXA(4)). Some nonsteroidal anti-inflammatory drugs (NSAIDs), which primarily act as cyclooxygenase inhibitors also inhibit LTB(4) 12-HD/PGR activity. Here we report the crystal structure of the LTB(4) 12-HD/PGR, the binary complex structure with NADP(+), and the ternary complex structure with NADP(+) and 15-oxo-PGE(2). In the ternary complex, both in the crystalline form and in solution, the enolate anion intermediate accumulates as a brown chromophore. PGE(2) contains two chains, but only the omega-chain of 15-oxo-PGE(2) was defined in the electron density map in the ternary complex structure. The omega-chain was identified at the hydrophobic pore on the dimer interface. The structure showed that the 15-oxo group forms hydrogen bonds with the 2'-hydroxyl group of nicotine amide ribose of NADP(+) and a bound water molecule to stabilize the enolate intermediate during the reductase reaction. The electron-deficient C13 atom of the conjugated enolate may be directly attacked by a hydride from the NADPH nicotine amide in a stereospecific manner. The moderate recognition of 15-oxo-PGE(2) is consistent with a broad substrate specificity of LTB(4) 12-HD/PGR. The structure also implies that a Src homology domain 3 may interact with the left-handed proline-rich helix at the dimer interface and regulate LTB(4) 12-HD/PGR activity by disruption of the substrate binding pore to accommodate the omega-chain.
 
  Selected figure(s)  
 
Figure 3.
FIG. 3. NADP+ and 15-oxo-PGE[2] binding to LTB[4] 12-HD/PGR. A, a stereo view of the bound NADP+ in the binary complex structure. The|F[o]| -|F[c]| simulated annealing omit electron density map is contoured at 3.0 (orange) and 6.0 (cyan). The carbon atoms of NADP+ are yellow, and those of side chains involved in NADP+ binding are green. Single-letter codes are used for amino acid residues. The water molecules, oxygen, nitrogen, and phosphorus atoms are colored pink, red, blue, and orange, respectively. The hydrogen bonds are indicated by dashed lines. The main chain nitrogen or carbonyl groups interacting with the bound NADP+ are labeled by residue numbers. B, a photo of the ternary complex crystals (0.3 x 0.2 x 0.1 mm). C, absorption spectrum changes of a ternary complex solution mixture. A 1:10 dilution of the ternary mixture after NaOH addition was measured. D, stereo view of the -chain of bound 15-oxo-PGE[2] in the ternary complex structure. The carbon atoms of the -chain of 15-oxo-PGE[2] are colored in cyan, and NADP+ in yellow. The residues from the same subunit of the bound NADP+ around the -chain hydrophobic pore are colored in green, and those from the other subunit are in magenta.|F[o]| -|F[c]| simulated annealing omit electron density map is contoured at 2.4 (orange) and 3.5 (blue). The residues Ala-241, Tyr-245, and Met-248 are located on the loop E- F. Tyr-273 was refined as two conformers. E, a stereo view of the interaction between the -chain and NADP+. The hydrogen bonds and the - orbital interactions between the nicotine amide ring and the conjugated double bonds of the -chain are indicated in dashed lines. The shortest distance of the - orbital interactions is 3.2 Å between the carbonyl oxygen atom of 15-oxo-PGE[2] and the nitrogen atom of the nicotine amide ring.
Figure 5.
FIG. 5. Schematic drawing of the enolate anion intermediate in 15-oxo-PGE[2] reductase reaction mechanism. Only the -chain and the cyclopentane ring are represented (see "Results and Discussion" for further details).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2004, 279, 22615-22623) copyright 2004.  
  Figures were selected by the author.  
 
 
    Author's comment    
 
  The LTB[4] 12-HD/PGR inhibitor, indomethacin complex was reported. (Hori, T. et al., J Biochem (Tokyo). (2006, 140,457-66)).  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21467222 A.Hassaninasab, Y.Hashimoto, K.Tomita-Yokotani, and M.Kobayashi (2011).
Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism.
  Proc Natl Acad Sci U S A, 108, 6615-6620.  
21216727 C.Shionyu-Mitsuyama, T.Waku, T.Shiraki, T.Oyama, T.Shirai, and K.Morikawa (2011).
Detecting structural similarity of ligand interactions in the lipid metabolic system including enzymes, lipid-binding proteins and nuclear receptors.
  Protein Eng Des Sel, 24, 397-403.  
21478637 H.Fujino, and T.Murayama (2011).
[Novel anti-cancer effects of indomethacin: exploring the cyclooxygenase-inhibition-independent effects].
  Nippon Yakurigaku Zasshi, 137, 177-181.  
20835842 S.Porté, A.Moeini, I.Reche, N.Shafqat, U.Oppermann, J.Farrés, and X.Parés (2011).
Kinetic and structural evidence of the alkenal/one reductase specificity of human ζ-crystallin.
  Cell Mol Life Sci, 68, 1065-1077.  
20804502 K.Okita, S.Motohashi, R.Shinnakasu, K.Nagato, K.Yamasaki, Y.Sato, H.Kitamura, A.Hijikata, M.Yamashita, K.Shimizu, S.Fujii, O.Ohara, M.Taniguchi, I.Sakaida, and T.Nakayama (2010).
A set of genes associated with the interferon-γ response of lung cancer patients undergoing α-galactosylceramide-pulsed dendritic cell therapy.
  Cancer Sci, 101, 2333-2340.  
19244215 M.W.Buczynski, D.S.Dumlao, and E.A.Dennis (2009).
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.
  J Lipid Res, 50, 1015-1038.  
19349281 S.Porté, E.Valencia, E.A.Yakovtseva, E.Borràs, N.Shafqat, J.E.Debreczeny, A.C.Pike, U.Oppermann, J.Farrés, I.Fita, and X.Parés (2009).
Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3.
  J Biol Chem, 284, 17194-17205.
PDB code: 2j8z
19154611 S.Tsuchiya, Y.Tachida, E.Segi-Nishida, Y.Okuno, S.Tamba, G.Tsujimoto, S.Tanaka, and Y.Sugimoto (2009).
Characterization of gene expression profiles for different types of mast cells pooled from mouse stomach subregions by an RNA amplification method.
  BMC Genomics, 10, 35.  
19011751 B.Persson, J.Hedlund, and H.Jörnvall (2008).
Medium- and short-chain dehydrogenase/reductase gene and protein families : the MDR superfamily.
  Cell Mol Life Sci, 65, 3879-3894.  
  18625039 L.H.Heckmann, R.M.Sibly, M.J.Timmermans, and A.Callaghan (2008).
Outlining eicosanoid biosynthesis in the crustacean Daphnia.
  Front Zool, 5, 11.  
18291039 L.H.Heckmann, R.M.Sibly, R.Connon, H.L.Hooper, T.H.Hutchinson, S.J.Maund, C.J.Hill, A.Bouetard, and A.Callaghan (2008).
Systems biology meets stress ecology: linking molecular and organismal stress responses in Daphnia magna.
  Genome Biol, 9, R40.  
18852632 R.C.De Lisle, L.Meldi, M.Flynn, and K.Jansson (2008).
Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine.
  J Pediatr Gastroenterol Nutr, 47, 406-416.  
18772430 T.Maier, M.Leibundgut, and N.Ban (2008).
The crystal structure of a mammalian fatty acid synthase.
  Science, 321, 1315-1322.
PDB codes: 2vz8 2vz9
19000823 Y.H.Wu, T.P.Ko, R.T.Guo, S.M.Hu, L.M.Chuang, and A.H.Wang (2008).
Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2.
  Structure, 16, 1714-1723.
PDB codes: 2zb3 2zb4 2zb7 2zb8
17009925 U.Oppermann (2007).
Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology.
  Annu Rev Pharmacol Toxicol, 47, 293-322.  
16645781 G.Ueno, H.Kanda, R.Hirose, K.Ida, T.Kumasaka, and M.Yamamoto (2006).
RIKEN structural genomics beamlines at the SPring-8; high throughput protein crystallography with automated beamline operation.
  J Struct Funct Genomics, 7, 15-22.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer